Advantech Capital L.P. 13D and 13G filings for Sinovac Biotech Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-14 06:16 am Unchanged | 2025-07-08 | 13D | SINOVAC BIOTECH LTD SVA | Advantech Capital L.P. | 5,851,423 8.140% | 0 (Unchanged) | Filing |
| 2025-04-10 06:12 am Unchanged | 2025-04-09 | 13D | SINOVAC BIOTECH LTD SVA | Advantech Capital L.P. | 5,851,423 8.140% | 0 (Unchanged) | Filing |
| 2025-03-25 10:48 am Unchanged | 2025-03-18 | 13D | SINOVAC BIOTECH LTD SVA | Advantech Capital L.P. | 5,851,423 8.140% | 0 (Unchanged) | Filing |
| 2024-03-20 07:33 am Sale | 2023-12-31 | 13G | SINOVAC BIOTECH LTD SVA | Advantech Capital L.P. | 5,851,423 8.160% | -48,577![]() (-0.82%) | Filing |
